Wael A H Hegazy1, Maan T Khayat2, Tarek S Ibrahim2,3,4, Mahmoud Youns5, Rasha Mosbah6, Wafaa E Soliman7,8. 1. Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt. waelmhegazy@daad-alumni.de. 2. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. 3. Center of Excellence for Drug Research & Pharmaceutical Industries, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. 4. Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt. 5. Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Helwan University, Cairo, Egypt. 6. Infection control Unit, Zagazig University Hospitals, Zagazig University, Zagazig, 44519, Egypt. 7. Department of Biomedical Sciences, College of Clinical Pharmacy, King Faisal University, AL AHSA, 31982, Kingdom of Saudi Arabia. 8. Microbiology and Immunology Department, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 35712, Egypt.
Abstract
BACKGROUND: Serratia marcescens becomes an apparent nosocomial pathogen and causes a variety of infections. S. marcescens possess various virulence factors that are regulated by intercellular communication system quorum sensing (QS). Targeting bacterial virulence is a proposed strategy to overcome bacterial resistance. Sitagliptin anti-QS activity has been demonstrated previously and we aimed in this study to investigate the effects of antidiabetic drugs vildagliptin and metformin compared to sitagliptin on S. marcescens pathogenesis. METHODS: We assessed the effects of tested drugs in subinhibitory concentrations phenotypically on the virulence factors and genotypically on the virulence encoding genes' expressions. The protection of tested drugs on S. marcescens pathogenesis was performed in vivo. Molecular docking study has been conducted to evaluate the interference capabilities of tested drugs to the SmaR QS receptor. RESULTS: Vildagliptin reduced the expression of virulence encoding genes but did not show in vitro or in vivo anti-virulence activities. Metformin reduced the expression of virulence encoding genes and inhibited bacterial virulence in vitro but did not show in vivo protection. Sitagliptin significantly inhibited virulence factors in vitro, reduced the expression of virulence factors and protected mice from S. marcescens. Docking study revealed that sitagliptin is more active than metformin and fully binds to SmaR receptor, whereas vildagliptin had single interaction to SmaR. CONCLUSION: The downregulation of virulence genes was not enough to show anti-virulence activities. Hindering of QS receptors may play a crucial role in diminishing bacterial virulence.
BACKGROUND: Serratia marcescens becomes an apparent nosocomial pathogen and causes a variety of infections. S. marcescens possess various virulence factors that are regulated by intercellular communication system quorum sensing (QS). Targeting bacterial virulence is a proposed strategy to overcome bacterial resistance. Sitagliptin anti-QS activity has been demonstrated previously and we aimed in this study to investigate the effects of antidiabetic drugs vildagliptin and metformin compared to sitagliptin on S. marcescens pathogenesis. METHODS: We assessed the effects of tested drugs in subinhibitory concentrations phenotypically on the virulence factors and genotypically on the virulence encoding genes' expressions. The protection of tested drugs on S. marcescens pathogenesis was performed in vivo. Molecular docking study has been conducted to evaluate the interference capabilities of tested drugs to the SmaR QS receptor. RESULTS: Vildagliptin reduced the expression of virulence encoding genes but did not show in vitro or in vivo anti-virulence activities. Metformin reduced the expression of virulence encoding genes and inhibited bacterial virulence in vitro but did not show in vivo protection. Sitagliptin significantly inhibited virulence factors in vitro, reduced the expression of virulence factors and protected mice from S. marcescens. Docking study revealed that sitagliptin is more active than metformin and fully binds to SmaR receptor, whereas vildagliptin had single interaction to SmaR. CONCLUSION: The downregulation of virulence genes was not enough to show anti-virulence activities. Hindering of QS receptors may play a crucial role in diminishing bacterial virulence.
Authors: Kishna Ram Senwar; Pankaj Sharma; T Srinivasa Reddy; Manish Kumar Jeengar; V Lakshma Nayak; V G M Naidu; Ahmed Kamal; Nagula Shankaraiah Journal: Eur J Med Chem Date: 2015-08-12 Impact factor: 6.514
Authors: Wayne L Nicholson; Michael T Leonard; Patricia Fajardo-Cavazos; Nedka Panayotova; William G Farmerie; Eric W Triplett; Andrew C Schuerger Journal: Genome Announc Date: 2013-08-15
Authors: Maan T Khayat; Tarek S Ibrahim; Ahdab N Khayyat; Majed Alharbi; Moataz A Shaldam; Khadijah A Mohammad; El-Sayed Khafagy; Dalia A El-Damasy; Wael A H Hegazy; Hisham A Abbas Journal: Microorganisms Date: 2022-05-18
Authors: Maan T Khayat; Hisham A Abbas; Tarek S Ibrahim; Ahdab N Khayyat; Majed Alharbi; Khaled M Darwish; Sameh S Elhady; El-Sayed Khafagy; Martin K Safo; Wael A H Hegazy Journal: Biomedicines Date: 2022-05-18
Authors: Ahmad J Almalki; Tarek S Ibrahim; Ehab S Taher; Mamdouh F A Mohamed; Mahmoud Youns; Wael A H Hegazy; Amany M M Al-Mahmoudy Journal: Molecules Date: 2022-01-20 Impact factor: 4.411
Authors: Ahdab N Khayyat; Wael A H Hegazy; Moataz A Shaldam; Rasha Mosbah; Ahmad J Almalki; Tarek S Ibrahim; Maan T Khayat; El-Sayed Khafagy; Wafaa E Soliman; Hisham A Abbas Journal: Microorganisms Date: 2021-05-18
Authors: Momen Askoura; Ahmad J Almalki; Amr S Abu Lila; Khaled Almansour; Farhan Alshammari; El-Sayed Khafagy; Tarek S Ibrahim; Wael A H Hegazy Journal: Microorganisms Date: 2021-12-11